 | • レポートコード：D0GIR-01655 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、小児てんかん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。小児てんかん治療の種類別市場規模（良性ローランドてんかん、小児欠神てんかん、若年性ミオクロニーてんかん、小児けいれん、レノックス・ガストー症候群）、用途別市場規模（病院、神経科センター、在宅医療環境、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Sanofi、Pfizer、GlaxoSmithKline、Bausch Health、Cephalon、Sunovion Pharmaceuticals、Novartis ・地域別グローバル市場分析 2015年-2020年 ・小児てんかん治療の北米市場（アメリカ、カナダ、メキシコ） ・小児てんかん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・小児てんかん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・小児てんかん治療の南米市場（ブラジル、アルゼンチン） ・小児てんかん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：良性ローランドてんかん、小児欠神てんかん、若年性ミオクロニーてんかん、小児けいれん、レノックス・ガストー症候群 ・用途別分析：病院、神経科センター、在宅医療環境、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Pediatric Epilepsy Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pediatric Epilepsy Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pediatric Epilepsy Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pediatric Epilepsy Therapeutics market has been segmented into:
Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gastaut Syndrome
By Application, Pediatric Epilepsy Therapeutics has been segmented into:
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pediatric Epilepsy Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Pediatric Epilepsy Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pediatric Epilepsy Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Pediatric Epilepsy Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pediatric Epilepsy Therapeutics Market Share Analysis
Pediatric Epilepsy Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pediatric Epilepsy Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pediatric Epilepsy Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Pediatric Epilepsy Therapeutics are:
Abbott Laboratories
Sanofi
Pfizer
GlaxoSmithKline
Bausch Health
Cephalon
Sunovion Pharmaceuticals
Novartis
Table of Contents
1 Pediatric Epilepsy Therapeutics Market Overview
1.1 Product Overview and Scope of Pediatric Epilepsy Therapeutics
1.2 Classification of Pediatric Epilepsy Therapeutics by Type
1.2.1 Global Pediatric Epilepsy Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type in 2019
1.2.3 Benign Rolandic Epilepsy
1.2.4 Childhood Absence Epilepsy
1.2.5 Juvenile Myoclonic Epilepsy
1.2.6 Infantile Spasms
1.2.7 Lennox-Gastaut Syndrome
1.3 Global Pediatric Epilepsy Therapeutics Market by Application
1.3.1 Overview: Global Pediatric Epilepsy Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.4 Global Pediatric Epilepsy Therapeutics Market by Regions
1.4.1 Global Pediatric Epilepsy Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pediatric Epilepsy Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pediatric Epilepsy Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pediatric Epilepsy Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pediatric Epilepsy Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pediatric Epilepsy Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pediatric Epilepsy Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bausch Health SWOT Analysis
2.5.4 Bausch Health Product and Services
2.5.5 Bausch Health Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cephalon
2.6.1 Cephalon Details
2.6.2 Cephalon Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cephalon SWOT Analysis
2.6.4 Cephalon Product and Services
2.6.5 Cephalon Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sunovion Pharmaceuticals
2.7.1 Sunovion Pharmaceuticals Details
2.7.2 Sunovion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sunovion Pharmaceuticals SWOT Analysis
2.7.4 Sunovion Pharmaceuticals Product and Services
2.7.5 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Pediatric Epilepsy Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pediatric Epilepsy Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pediatric Epilepsy Therapeutics Players Market Share
3.2.2 Top 10 Pediatric Epilepsy Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Regions
4.2 North America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Pediatric Epilepsy Therapeutics Revenue by Countries
5.1 North America Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
5.2 USA Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Pediatric Epilepsy Therapeutics Revenue by Countries
6.1 Europe Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue by Countries
7.1 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
7.2 China Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Pediatric Epilepsy Therapeutics Revenue by Countries
8.1 South America Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pediatric Epilepsy Therapeutics by Countries
9.1 Middle East & Africa Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Pediatric Epilepsy Therapeutics Market Forecast by Type (2019-2024)
10.3 Benign Rolandic Epilepsy Revenue Growth Rate (2015-2025)
10.4 Childhood Absence Epilepsy Revenue Growth Rate (2015-2025)
10.5 Juvenile Myoclonic Epilepsy Revenue Growth Rate (2015-2025)
10.6 Infantile Spasms Revenue Growth Rate (2015-2025)
10.7 Lennox-Gastaut Syndrome Revenue Growth Rate (2015-2025)
11 Global Pediatric Epilepsy Therapeutics Market Segment by Application
11.1 Global Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Pediatric Epilepsy Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Neurology Centers Revenue Growth (2015-2020)
11.5 Home Care Settings Revenue Growth (2015-2020)
11.6 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Pediatric Epilepsy Therapeutics Market Size Forecast (2021-2025)
12.1 Global Pediatric Epilepsy Therapeutics Market Size Forecast (2021-2025)
12.2 Global Pediatric Epilepsy Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pediatric Epilepsy Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pediatric Epilepsy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pediatric Epilepsy Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pediatric Epilepsy Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Pediatric Epilepsy Therapeutics Major Business
Table 7. Abbott Laboratories Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Pediatric Epilepsy Therapeutics Product and Solutions
Table 10. Abbott Laboratories Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Pediatric Epilepsy Therapeutics Major Business
Table 13. Sanofi Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Pediatric Epilepsy Therapeutics Product and Solutions
Table 16. Sanofi Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Pediatric Epilepsy Therapeutics Major Business
Table 19. Pfizer Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Pediatric Epilepsy Therapeutics Product and Solutions
Table 22. Pfizer Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Pediatric Epilepsy Therapeutics Major Business
Table 25. GlaxoSmithKline Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Pediatric Epilepsy Therapeutics Product and Solutions
Table 28. GlaxoSmithKline Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bausch Health Corporate Information, Location and Competitors
Table 30. Bausch Health Pediatric Epilepsy Therapeutics Major Business
Table 31. Bausch Health Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Bausch Health SWOT Analysis
Table 33. Bausch Health Pediatric Epilepsy Therapeutics Product and Solutions
Table 34. Bausch Health Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cephalon Corporate Information, Location and Competitors
Table 36. Cephalon Pediatric Epilepsy Therapeutics Major Business
Table 37. Cephalon Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Cephalon SWOT Analysis
Table 39. Cephalon Pediatric Epilepsy Therapeutics Product and Solutions
Table 40. Cephalon Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sunovion Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Major Business
Table 43. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Sunovion Pharmaceuticals SWOT Analysis
Table 45. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Product and Solutions
Table 46. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Pediatric Epilepsy Therapeutics Major Business
Table 49. Novartis Pediatric Epilepsy Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Pediatric Epilepsy Therapeutics Product and Solutions
Table 52. Novartis Pediatric Epilepsy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Pediatric Epilepsy Therapeutics Revenue Share by Players (2015-2020)
Table 55. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Regions (2015-2020)
Table 57. North America Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
Table 58. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Pediatric Epilepsy Therapeutics Revenue by Countries (2015-2020)
Table 62. South America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Pediatric Epilepsy Therapeutics Revenue Share by Type (2015-2020)
Table 67. Global Pediatric Epilepsy Therapeutics Revenue Forecast by Type (2021-2025)
Table 68. Global Pediatric Epilepsy Therapeutics Revenue by Application (2015-2020)
Table 69. Global Pediatric Epilepsy Therapeutics Revenue Share by Application (2015-2020)
Table 70. Global Pediatric Epilepsy Therapeutics Revenue Forecast by Application (2021-2025)
Table 71. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pediatric Epilepsy Therapeutics Picture
Figure 2. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type in 2019
Figure 3. Benign Rolandic Epilepsy Picture
Figure 4. Childhood Absence Epilepsy Picture
Figure 5. Juvenile Myoclonic Epilepsy Picture
Figure 6. Infantile Spasms Picture
Figure 7. Lennox-Gastaut Syndrome Picture
Figure 8. Pediatric Epilepsy Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Neurology Centers Picture
Figure 11. Home Care Settings Picture
Figure 12. Ambulatory Surgical Centers Picture
Figure 13. Global Pediatric Epilepsy Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Pediatric Epilepsy Therapeutics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Pediatric Epilepsy Therapeutics Revenue Market Share in 2019
Figure 22. Global Top 10 Players Pediatric Epilepsy Therapeutics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 26. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Regions in 2018
Figure 27. North America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Europe Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. South America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 33. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries in 2019
Figure 34. USA Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Canada Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Europe Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Pediatric Epilepsy Therapeutics Revenue Market Share by Countries in 2019
Figure 39. Germany Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. UK Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. France Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Russia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Italy Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Market Share by Countries in 2019
Figure 46. China Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Japan Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Korea Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. India Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. South America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. South America Pediatric Epilepsy Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Brazil Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. UAE Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. Global Pediatric Epilepsy Therapeutics Revenue Share by Type (2015-2020)
Figure 62. Global Pediatric Epilepsy Therapeutics Revenue Share by Type in 2019
Figure 63. Global Pediatric Epilepsy Therapeutics Market Share Forecast by Type (2021-2025)
Figure 64. Global Benign Rolandic Epilepsy Revenue Growth Rate (2015-2020)
Figure 65. Global Childhood Absence Epilepsy Revenue Growth Rate (2015-2020)
Figure 66. Global Juvenile Myoclonic Epilepsy Revenue Growth Rate (2015-2020)
Figure 67. Global Infantile Spasms Revenue Growth Rate (2015-2020)
Figure 68. Global Lennox-Gastaut Syndrome Revenue Growth Rate (2015-2020)
Figure 69. Global Pediatric Epilepsy Therapeutics Revenue Share by Application (2015-2020)
Figure 70. Global Pediatric Epilepsy Therapeutics Revenue Share by Application in 2019
Figure 71. Global Pediatric Epilepsy Therapeutics Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Neurology Centers Revenue Growth Rate (2015-2020)
Figure 74. Global Home Care Settings Revenue Growth Rate (2015-2020)
Figure 75. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 76. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Pediatric Epilepsy Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Pediatric Epilepsy Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Europe Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. South America Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
てんかん治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Epilepsy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1997.1 million by 2025, from USD 1892.4 million in 2019. The Epilepsy Drug market r…- てんかんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Epilepsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- てんかん診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Epilepsy Diagnosis & Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 13710 million by 2025, from USD 8003.9 million in 2019. The Epile…
- 小児神経芽細胞腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pediatric Neuroblastoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.8% in the forecast period of 2020 to 2025 and will expected to reach USD 724.1 million by 2025, from USD 599.6 million in 2019. The Pedi…
- 小児放射線の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pediatric Radiology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 2104.4 million by 2025, from USD 1786.6 million in 2019. The Pediatric Radiol…